GLPwatch
Clinical Study of 18F-Exendin-4 in Insulinoma
NCT07340437 · Completed
Last updated 2026-05-28This clinical trial is testing a new imaging agent called 18F-Exendin-4 in people suspected of having an insulinoma to see how well it works with PET/CT scans.
Status Completed The study has finished.
Type Observational
Participants 20 people
Who can join Ages 18+ · all sexes
Timeline Started 2023-02 · est. completion 2025-12
Where 1 site · China
What this study is testing ClinicalTrials.gov NCT07340437 ↗
Description as written by the study sponsor.
The goal of this observational study is to evaluate the diagnostic value of ¹⁸F-Exendin-4 PET/CT imaging in renal insulinoma. Participants will undergo clinical evaluation and ¹⁸F-Exendin-4 PET/CT examination.
| Main thing measured | Correlation between clinical indicators and PET/CT results |
|---|---|
| Sponsor | Sichuan Provincial People's Hospital |
| Conditions studied | Insulinoma |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07340437 ↗